Laboratory Corporation Of America Holdings (LH): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Laboratory Corporation of America Holdings ( LH) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 2.0%. By the end of trading, Laboratory Corporation of America Holdings rose $3.93 (4.2%) to $98.64 on heavy volume. Throughout the day, 4,218,852 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 1,040,200 shares. The stock ranged in a price between $97.50-$102.00 after having opened the day at $97.50 as compared to the previous trading day's close of $94.71. Other companies within the Health Care sector that increased today were: Keryx Biopharmaceuticals ( KERX), up 17.4%, IsoRay ( ISR), up 12.6%, Fate Therapeutics ( FATE), up 11.6% and Conatus Pharmaceuticals ( CNAT), up 6.2%.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.1 billion and is part of the health services industry. Shares are up 3.7% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the negative front, Exelixis ( EXEL), down 39.4%, Relypsa ( RLYP), down 19.3%, Aastrom Biosciences ( ASTM), down 15.2% and Insmed ( INSM), down 13.1% , were all laggards within the health care sector with Forest Laboratories ( FRX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Centene, LabCorp Among Healthcare Stock Gainers

Centene, LabCorp Among Healthcare Stock Gainers

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

INC Research Holdings Seen as Likely LabCorp. Takeover Target

INC Research Holdings Seen as Likely LabCorp. Takeover Target

5 Big Stocks to Buy for Big Gains

5 Big Stocks to Buy for Big Gains